These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7584960)
1. Elimination of Ehrlich tumours by ATP-induced growth inhibition, glutathione depletion and X-rays. Estrela JM; Obrador E; Navarro J; Lasso De la Vega MC; Pellicer JA Nat Med; 1995 Jan; 1(1):84-8. PubMed ID: 7584960 [TBL] [Abstract][Full Text] [Related]
2. Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth. Terradez P; Asensi M; Lasso de la Vega MC; Puertes IR; ViƱa J; Estrela JM Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):477-83. PubMed ID: 8503882 [TBL] [Abstract][Full Text] [Related]
3. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508. Yu NY; Brown JM Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of cancer growth and selective glutathione depletion in Ehrlich tumour cells in vivo by extracellular ATP. Lasso de la Vega MC; Terradez P; Obrador E; Navarro J; Pellicer JA; Estrela JM Biochem J; 1994 Feb; 298 ( Pt 1)(Pt 1):99-105. PubMed ID: 8129737 [TBL] [Abstract][Full Text] [Related]
5. Effect of L-buthionine sulfoximine on the radiation response of human renal carcinoma cell lines. Leung SW; Mitchell JB; al-Nabulsi I; Friedman N; Newsome J; Belldegrun A; Kasid U Cancer; 1993 Apr; 71(7):2276-85. PubMed ID: 8095848 [TBL] [Abstract][Full Text] [Related]
6. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation. Shrieve DC; Harris JW Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936 [TBL] [Abstract][Full Text] [Related]
7. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio. Mitchell JB; Russo A; Biaglow JE; McPherson S Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769 [TBL] [Abstract][Full Text] [Related]
8. Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis. Campbell EB; Hayward ML; Griffith OW Anal Biochem; 1991 May; 194(2):268-77. PubMed ID: 1677799 [TBL] [Abstract][Full Text] [Related]
9. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells. Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425 [TBL] [Abstract][Full Text] [Related]
10. Radiosensitization of mouse skin by oxygen and depletion of glutathione. Stevens G; Joiner M; Joiner B; Johns H; Denekamp J Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):399-408. PubMed ID: 7673027 [TBL] [Abstract][Full Text] [Related]
11. Radiosensitizers: a conference preview. Adams GE Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1181-4. PubMed ID: 6236183 [No Abstract] [Full Text] [Related]
12. Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo. Obrador E; Navarro J; Mompo J; Asensi M; Pellicer JA; Estrela JM Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):183-9. PubMed ID: 9224645 [TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine. Malaker K; Hurwitz SJ; Bump EA; Griffith OW; Lai LL; Riese N; Coleman CN Int J Radiat Oncol Biol Phys; 1994 May; 29(2):407-12. PubMed ID: 7910818 [TBL] [Abstract][Full Text] [Related]
14. Depletion of glutathione by L-buthionine sulfoximine does not promote inactivation of myo-inositol transport in cultured bovine lens epithelial cells. Cammarata PR; Tse D; Yorio T Curr Eye Res; 1991 Apr; 10(4):321-30. PubMed ID: 1676962 [TBL] [Abstract][Full Text] [Related]
15. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer. Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140 [TBL] [Abstract][Full Text] [Related]
16. Radiosensitizing effect of misonidazole in combination with an inhibitor of glutathione synthesis in murine tumors. Ono K; Komuro C; Nishidai T; Shibamoto Y; Tsutsui K; Takahashi M; Abe M Int J Radiat Oncol Biol Phys; 1986 Sep; 12(9):1661-6. PubMed ID: 3759592 [TBL] [Abstract][Full Text] [Related]
17. Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine. Lee FY; Allalunis-Turner MJ; Siemann DW Br J Cancer; 1987 Jul; 56(1):33-8. PubMed ID: 3620316 [TBL] [Abstract][Full Text] [Related]
18. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery. Bertsche U; Schorn H Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339 [TBL] [Abstract][Full Text] [Related]
19. Glutathione modulation in cancer treatment: will it work? Mitchell JB; Cook JA; DeGraff W; Glatstein E; Russo A Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1289-95. PubMed ID: 2654105 [TBL] [Abstract][Full Text] [Related]
20. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion. Kang YJ; Enger MD Am J Physiol; 1992 Jan; 262(1 Pt 1):C122-7. PubMed ID: 1733228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]